Beijing Aosaikang Pharmaceutical Co.,Ltd. Posted 95.9 Million Yuan Net Loss in First Three Quarters of 2022

Beijing Aosaikang Pharmaceutical Co.,Ltd. (北京奥赛康药业股份有限公司) (002755.SZ) reported a net loss of 95.9 million yuan in the first three quarters of 2022, reversing a net profit of 386.2 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.5 billion yuan in revenue, down 38.4% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 394.4 million yuan in total liabilities, with a liability-to-asset ratio of 11%.